The global cell expansion market size is estimated to be USD 15.82 billion in 2021 and is expected to witness a CAGR of 12.85% during the forecast period. Increasing prevalence of chronic diseases, investment opportunities in cell-based therapy and biotechnology industry, rise in the use of the automated solutions for the purpose of cell expansion major factor that boosts the global market growth. Also, the preference for gene therapy and use of biologics are some of the other factors that help in the growth during the forecast period. However, the risk of toxicity in animals and human beings in the course of research along with the ethical concerns with cell biology research are some of the factors hindering the market growth.

By Product

Based on the product, the global market is segmented into consumables, culture flasks and accessories and accessories, and instruments. In 2021, the consumables segment accounted for the largest revenue share owing to the rise in the demand for vaccines and other biopharmaceuticals, like biologic drugs for cancer treatment. However, the instruments segment is estimated to grow at the highest CAGR during the forecast period. This can be attributed to the automation of the bioreactors leading to high-efficiency performance.

By Cell Type

Based on the technique, the market is categorized into mammalian and microbial cells majorly. In 2021, the mammalian cells segment accounted for their high similarity to humans and hence can be used for various pharmacokinetic research. Human stem cells are having high demand and expected to post the highest growth rate in the forecast period due to the use of regenerative medicine and personalized medications in the medical research arena. The differentiated human cells have gained market share due to the demand rise in skin engineering.

By Application

Based on the application, the market is divided into biopharmaceutical, tissue culture, vaccine production, drug development. The biopharmaceutical segment was the highest revenue-grossing segment in 2021. This is due to the approval of biopharmaceutical product approval in the past years. Single-use technologies are gaining importance because of the increase in cell-based therapies. The vaccine segment will post the highest growth rate in the forecast period owing to the high adoption of cell-based therapy and regenerative medications among the patients.

By End-User

Based on end-user, biopharmaceuticals, research institutes, and cell banks are some of the important segments. The biopharmaceutical segment was the highest revenue grossing segment in 2021 due to the high preference for cell-based therapy in place of the traditional injectables for drug delivery. Inorganic growth is also taking place in the segment.  Such as in 2021, Sartorius AG is in the process of acquisition of 50% of Biological Industries, which is into the cell culture manufacturing industry. The research institutes are expected to post the highest rate of growth and it may be attributed to a high number of researches that are happening in the biopharmaceutical field.

Regional Insights

In 2021, North America accounted for the highest revenue share in the global market and is expected to remain the leader during the forecast period. This may be attributed to the high number of government and private investments as well as increased preference for cell-based therapy. The Asia Pacific is projected to exhibit the fastest CAGR over the forecast period due to the push in the use of cell-based therapy medications in the region apart from the inorganic growth by various firms.

Competitor Insights

Some of the key players in the global cell expansion market are Thermo Fisher Scientific (U.S.), Lonza (Switzerland), Danaher (U.S.), Corning (U.S.), Becton, Dickinson and Company (U.S.), Merck (Germany), STEMCELL Technologies Inc. (Canada), Terumo (Japan), Miltenyi Biotec (Germany), and Sartorius Stedim Biotech (France). The leading players operating in the global cell expansion market are adopting various strategies such as collaborations, mergers & acquisitions, new product launch, and regional expansions to capture a maximum revenue share.

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The cell expansion market report is categorized into the following segments and subsegments:

Global Cell Expansion Market By Product (Revenue, 2021 – 2029, USD Billion)

• Consumables
  • Reagents, media, & serum
  • Other consumables

• Culture flasks and accessories

• • Tissue Culture Flasks
  • Bioreactor Accessories
  • Others
• Instruments
  • Automated Cell Expansion Systems
  • Cell Counters
  • Centrifuges
  • Bioreactors
  • Others

Cell Expansion Market, By Cell Type (Revenue, 2021 – 2029, USD Billion)

• Mammalian Cells
• Human Cells
• Stem Cells
• Adult Stem Cells
• Induced Pluripotent Stem Cells
• Embryonic Stem Cells
• Differentiated Cells
• Animal Cells
• Microbial Cells
• Others

Cell Expansion Market, By Application (Revenue, 2021 – 2029, USD Billion)

• Biopharmaceuticals
• Tissue Culture & Engineering
• Vaccine Production
• Drug Development
• Gene Therapy
• Cancer Research
• Stem Cell Research
• Other Applications

Cell Expansion Market, By End-User (Revenue, 2021 – 2029, USD Billion)

• Biotechnology and biopharmaceutical companies
• Research Institutes
• Cell Banks
• Others

Blood Culture Tests Market, By Region (Revenue, 2021 – 2029, USD Billion)

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • Australia
  • South Korea
  • India
  • Rest of APAC
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Rest of MEA

Scope of Global Cell Expansion Market Report:

Key Parameters	Details
Base Year	2021
Forecast Period	2022-2029
Study Coverage	Global and regional market size and revenue forecast Segment market size and revenue forecast at global, regional, and country level Competitive landscape (company share analysis, company profiles, recent development, competitive map analysis) Conclusion and recommendations
Qualitative Analysis	Market drivers Market restraints Market opportunities Recent market trends Market challenges Porter’s Five Forces analysis PEST analysis Value-chain analysis COVID-19 impact analysis
Regional Market Scope	North America (U.S. and Canada) Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe) Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC) Latin America (Brazil, Mexico, Argentina, Rest of LATAM) MEA (South Africa, GCC, Rest of MEA)
Company Profiles	Exhaustive profiles of top 15 players 50+ other major players listing
15% Free Customization Available	You can customize the study scope to meet your exact requirement. Click here for more details